Development of a cellular model to study alternative splicing of type II collagen gene

To study regulation of alternative splicing of type II collagen (COL2) pre-mRNA, we constructed a mouse COL2 “minigene” containing genomic sequences spanning exon 1 to exon 4 of COL2 downstream of a cytomegalovirus (CMV) promoter. This minigene was introduced into ATDC5 cells, which undergo chondroc...

Full description

Saved in:
Bibliographic Details
Published in:Journal of orthopaedic research 2002-05, Vol.20 (3), p.516-519
Main Authors: Hatano, H, Sarkar, G, Bolander, M.E
Format: Article
Language:English
Subjects:
Alternative Splicing
Animals
Cell Line
Collagen Type II - genetics
Cytomegalovirus - genetics
Mice
Peptide Fragments - genetics
Promoter Regions, Genetic - genetics
RNA Precursors - genetics
RNA, Messenger - metabolism
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:To study regulation of alternative splicing of type II collagen (COL2) pre-mRNA, we constructed a mouse COL2 “minigene” containing genomic sequences spanning exon 1 to exon 4 of COL2 downstream of a cytomegalovirus (CMV) promoter. This minigene was introduced into ATDC5 cells, which undergo chondrocytic differentiation when treated with insulin. Alternative splicing of the COL2 minigene was evaluated by comparing the expression of the two mRNAs transcribed from the minigene to the expression of alternatively spliced transcripts from the endogenous COL2 gene. This analysis suggested that regulation of alternative splicing of pre-mRNAs from the minigene and the endogenous COL2 gene are accomplished by similar mechanisms. We conclude that the cloned genomic fragment contains key sequences necessary for alternative splicing of COL2 pre-mRNA. This system provides a useful model to begin the process of identifying cis- and trans-acting factors that carry out alternative splicing of COL2 pre-mRNA during chondrocyte differentiation.
ISSN:0736-0266
1554-527X
DOI:10.1016/S0736-0266(01)00123-1